Federated Hermes’s scPharmaceuticals SCPH Stock Holding History

Federated Hermes’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55	Closed	-$560	–	2187
2023 Q2	$560	Sell	55 -206	-79%	-$2.15K	﹤0.01%	2052
2023 Q1	$2.37K	Buy	+261	New	+$1.91K	﹤0.01%	1994
2020 Q4	–	Sell	-87	Closed	-$1K	–	2313
2020 Q3	$1K	Sell	87 -168	-66%	-$1.31K	﹤0.01%	2188
2020 Q2	$2K	Buy	+255	New	+$2.24K	﹤0.01%	2092
2019 Q4	–	Sell	-42	Closed	-$1K	–	2296
2019 Q3	$1K	Buy	+42	New	+$237	﹤0.01%	2131

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Federated Hermes's SCPH Position: Q3 2023 in Review

Federated Hermes sold out of scPharmaceuticals (SCPH) in Q3 2023, closing a stake of 55 shares — an estimated $560 sold.

Federated Hermes first reported a position in SCPH in Q3 2019 and held it in 5 quarters. The position peaked at $2.37K in Q1 2023. 73 funds tracked by Wall St. Rank hold SCPH as of Q3 2023.

Federated Hermes reported no remaining scPharmaceuticals position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 55 scPharmaceuticals shares in Q3 2023, an estimated $560.
Federated Hermes first reported a position in scPharmaceuticals in Q3 2019 and held it in 5 quarters.
Federated Hermes's scPharmaceuticals position peaked at $2.37K in Q1 2023.
73 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.